Sinopharm Group Co Ltd
F:X2S1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sinopharm Group Co Ltd
F:X2S1
|
CN |
|
A
|
Aristocrat Leisure Ltd
SWB:AC8
|
AU |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
CA |
|
E
|
Encompass Health Corp
SWB:HSOA
|
US |
|
B
|
Bayer AG
BET:BAYER
|
DE |
|
D
|
Danaher Corp
DUS:DAP
|
US |
|
M
|
Marsh & McLennan Companies Inc
SWB:MSN
|
US |
|
Hindalco Industries Ltd
BSE:500440
|
IN |
|
K
|
KLA Corp
XBER:KLA
|
US |
|
G
|
Goldman Sachs Group Inc
F:GOS
|
US |
|
S
|
Singapore Airlines Ltd
OTC:SINGF
|
SG |
|
I
|
Intel Corp
DUS:INL
|
US |
|
H
|
Henry Schein Inc
DUS:HS2
|
US |
|
W
|
Weatherford International PLC
F:0WE
|
US |
|
DIP Corp
OTC:DPRTF
|
JP |
|
V
|
Vulcan Materials Co
DUS:VMC
|
US |
|
B
|
Bank of America Corp
XHAM:NCB
|
US |
|
P
|
Parker-Hannifin Corp
XBER:PAR
|
US |
|
C
|
Columbus McKinnon Corp
F:VC3
|
US |
|
B
|
Boston Scientific Corp
LSE:0HOY
|
US |
Wall St Price Targets
X2S1 Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for X2S1 is 12.87 EUR with a low forecast of 10.36 EUR and a high forecast of 15.7 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is X2S1's stock price target?
Price Target
12.87
EUR
According to Wall Street analysts, the average 1-year price target for X2S1 is 12.87 EUR with a low forecast of 10.36 EUR and a high forecast of 15.7 EUR.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 10%.
